Ethyl 2-methylsulfanyl-5-oxo-8-phenyl-6,7-dihydropyrido[2,3-d]pyrimidine-6-carboxylate | 100426-80-0

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: Ethyl 2-methylsulfanyl-5-oxo-8-phenyl-6,7-dihydropyrido[2,3-d]pyrimidine-6-carboxylate
• CAS: 100426-80-0
• 化学式: C₁₇H₁₇N₃O₃S
• 分子量: 343.406
• InChiKey: JYZWXJWEQPNDCQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  24
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  97.7
• 氢给体数：
  0
• 氢受体数：
  7

反应信息

• 作为反应物：
  描述：

  Ethyl 2-methylsulfanyl-5-oxo-8-phenyl-6,7-dihydropyrido[2,3-d]pyrimidine-6-carboxylate 在 溴 作用下， 以 二氯甲烷 为溶剂， 生成
  参考文献：
  名称：

  Design and synthesis of a pyrido[2,3-d]pyrimidin-5-one class of anti-inflammatory FMS inhibitors

  摘要：

  A series of pyrimidinopyridones has been designed, synthesized and shown to be potent and selective inhibitors of the FMS tyrosine kinase. Introduction of an amide substituent at the 6-position of the pyridone core resulted in a significant potency increase. Compound 24 effectively inhibited in vivo LPS-induced TNF in mice greater than 80%. (C) 2008 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2008.02.070
• 作为产物：
  描述：

  ethyl 4-(N-(3-ethoxy-3-oxopropyl)anilino)-2-methylsulfanylpyrimidine-5-carboxylate 在 sodium t-butanolate 作用下， 以 甲苯 为溶剂， 生成 Ethyl 2-methylsulfanyl-5-oxo-8-phenyl-6,7-dihydropyrido[2,3-d]pyrimidine-6-carboxylate
  参考文献：
  名称：

  Design and synthesis of a pyrido[2,3-d]pyrimidin-5-one class of anti-inflammatory FMS inhibitors

  摘要：

  A series of pyrimidinopyridones has been designed, synthesized and shown to be potent and selective inhibitors of the FMS tyrosine kinase. Introduction of an amide substituent at the 6-position of the pyridone core resulted in a significant potency increase. Compound 24 effectively inhibited in vivo LPS-induced TNF in mice greater than 80%. (C) 2008 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2008.02.070

文献信息

• 5-OXO-5,8-DIHYDRO-PYRIDO-PYRIMIDINES AS INHIBITORS OF C-FMS KINASE
  申请人：Player R. Mark

  公开号：US20080114007A1

  公开（公告）日：2008-05-15

  The invention addresses the current need for selective and potent protein tyrosine kinase inhibitors by providing potent inhibitors of c-fms kinase. The invention is directed to the novel compounds of Formula I: or a salt, stereoisomer, tautomer, crystalline, polymorph, amorphous, solvate, hydrate, ester, prodrug or metabolite form thereof, wherein A, Y, Z, R 101 and R 200 are described in the specification.

  本发明针对当前对选择性和强效蛋白酪氨酸激酶抑制剂的需求，提供对c-fms激酶的强效抑制剂。本发明涉及以下式I的新化合物： 或其盐、对映体、互变异构体、结晶、多晶型、无定形、溶剂化物、水合物、酯、前药或代谢物形式，其中A、Y、Z、R 101 和R 200 在说明书中有描述。
• 5-Oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of c-fms kinase
  申请人：Player R. Mark

  公开号：US20070060577A1

  公开（公告）日：2007-03-15

  The invention addresses the current need for selective and potent protein tyrosine kinase inhibitors by providing potent inhibitors of c-fms kinase. The invention is directed to the novel compounds of Formula I: or a solvate, hydrate, tautomer or pharmaceutically acceptable salt thereof, wherein: W, A, Y, Z, R 101 and R 200 are described in the specification.

  该发明通过提供c-fms激酶的有效抑制剂来解决当前对选择性和强效蛋白酪氨酸激酶抑制剂的需求。该发明涉及公式I的新化合物：或其溶剂化合物、水合物、互变异构体或药用可接受的盐，其中：W、A、Y、Z、R101和R200如规范中所述。
• Naphthyridine antibacterial compounds
  申请人：ABBOTT LABORATORIES

  公开号：EP0153580A1

  公开（公告）日：1985-09-04

  Compounds having the formula: wherein Z is an amine or a aliphatic heterocyclic group, R is a phenyl group or an aromatic heterocyclic group, R1 is hydrogen or a carboxy protecting group and B is N or CF. The compounds of the invention have antibacterial activity.

  具有以下式子的化合物： 其中 Z 是胺或脂肪杂环基团，R 是苯基或芳香杂环基团，R1 是氢或羧基保护基团，B 是 N 或 CF。 本发明的化合物具有抗菌活性。
• US7642270B2
  申请人：——

  公开号：US7642270B2

  公开（公告）日：2010-01-05
• US7728003B2
  申请人：——

  公开号：US7728003B2

  公开（公告）日：2010-06-01